Viewing data from:

KETOCONAZOLE

ANDA

KETOCONAZOLE | A213601 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$5.79

per gm

Lowest NADAC/Unit

$3.00

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70700016019KETOCONAZOLE 2% FOAM	$5.79	GM	Generic	—	2026-06-17
70700016020KETOCONAZOLE 2% FOAM	$3.00	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$187.34

Highest Price

$219.24

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
70700-0160-19KETOCONAZOLE 2% FOAM,TOP	$187.34	FSS	AvKare, LLC	06/14/2028
70700-0160-20KETOCONAZOLE 2% FOAM,TOP	$219.24	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs8 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

JANSSEN PHARMACEUTICA NVKETOCONAZOLE DRUG SUBSTANCE

DMF 100371993

QUIMICA SINTETICA SAKETOCONAZOLE

DMF 120231996

DERIVADOS QUIMICOS SAUKETOCONAZOLE

DMF 147942001

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)KETOCONAZOLE

DMF 162122002

PIRAMAL PHARMA LTDKETOCONAZOLE

DMF 172902004

SHARON BIO MEDICINE LTDKETOCONAZOLE USP

DMF 250132011

STHREE CHEMICALS LLCKETOCONAZOLE USP

DMF 384172023

QUIMICA SINTETICA SAInactiveKETOCONAZOLE

DMF 97181992

ESTEVE QUIMICA SAInactiveKETOCONAZOLE

DMF 115791995

ALBEMARLE CORPInactiveKETOCONAZOLE

DMF 121711996

QUIMICA FINA FARMEX SA DE CVInactiveKETOCONAZOLE

DMF 127941997

NAPP TECHNOLOGIES INCInactiveKETOCONAZOLE USP

DMF 149482000

RECORDATI ESPANA SLInactiveKETOCONAZOLE

DMF 159602002

FDC LTDInactiveKETOCONAZOLE

DMF 168022003

GUFIC BIOSCIENCES LTDInactiveKETOCONAZOLE USP

DMF 169152003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 2%

0 patents0 exclusivities▴

AEROSOL, FOAM;TOPICAL | Approved: May 21, 2021

No patent or exclusivity listings for this strength.